glp-1 receptor agonists in idiopathic intracranial hypertension The effect of agonist on hypertension: a systematic review and meta-analysis Large-Scale Study Highlights Therapeutic Benefits

Weight Loss Effect of Glucagon-Like Peptide-1 Mimetics on Obese/Overweight Adults Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Pereira, S

TripleHormone-Receptor agonist Retatrutide for Obesity A phase 2 trial

Briefly, the first GLP-1RA started with administration twice-daily (BID

Improved Glycemic Control : Individuals with type 2 diabetes benefit immensely from the glucose-regulating effects of GLP-1 agonists, which enhance insulin secretion and inhibit glucagon production, promoting better glycemic control

This was despite the fact that the work behind the patent, filed in 1997 and granted in 2001, demonstrated that the peptide helped to lower body weight for four weeks in type 2 diabetes patients who were obese (DiMarchi, Efendic)